Shigeo Kinomura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shigeo Kinomura has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Fukuda
4 shared publicationsMasatoshi Itoh
3 shared publicationsRyuta Kawashima
Institute of Development, Aging and Cancer(IDAC), Tohoku University, 980-8575, Sendai, Japan
2 shared publicationsTakehiko Fujiwara
Cyclotron Radio Isotope Center(CYRIC), Tohoku University, Sendai, Japan
2 shared publications- Tomohiro Kaneta
Department of Radiology, Graduate School of Medicine, Tohoku University, Sendai, Japan
2 shared publications Hideyuki Kurihara
1 shared publication
Latest Publications
- 30 May 2008
- Vol. 55 (81) , 46-9
Increase of serum CA19-9 level without an evident lesion on conventional imaging is insufficient for justification of 18FDG-PET examination.
The serum tumor marker carbohydrate associated antigen 19-9 (CA19-9) has been used for screening for cancer, because its increase has been associated with many cancers. We aimed to evaluate the clinical value of positron emission tomography using F-18 fluorodeoxyglucose (18FDG-PET) that was prompted by increases of serum CA19-9 without findings on conventional imaging. Twenty-two patients were retrospectively selected. Eleven were without a history of cancer and eleven had a history of cancer and were treated with curative intent. All 18FDG-PET findings were compared with the findings of histopathology by surgery or biopsy, or clinical follow-up for at least 1 year. We found only two true positive cases, and eleven cases without a cancer history included 10 true negatives and one false positive. Increases in serum CA19-9 are caused by many benign conditions. Increases of CA19-9 without findings on conventional imaging do not justify 18FDG-PET examination, particularly in patients without a cancer history.
- 30 May 2008
- Vol. 55 (81) , 46-9
Increase of serum CA19-9 level without an evident lesion on conventional imaging is insufficient for justification of 18FDG-PET examination.
The serum tumor marker carbohydrate associated antigen 19-9 (CA19-9) has been used for screening for cancer, because its increase has been associated with many cancers. We aimed to evaluate the clinical value of positron emission tomography using F-18 fluorodeoxyglucose (18FDG-PET) that was prompted by increases of serum CA19-9 without findings on conventional imaging. Twenty-two patients were retrospectively selected. Eleven were without a history of cancer and eleven had a history of cancer and were treated with curative intent. All 18FDG-PET findings were compared with the findings of histopathology by surgery or biopsy, or clinical follow-up for at least 1 year. We found only two true positive cases, and eleven cases without a cancer history included 10 true negatives and one false positive. Increases in serum CA19-9 are caused by many benign conditions. Increases of CA19-9 without findings on conventional imaging do not justify 18FDG-PET examination, particularly in patients without a cancer history.
- 1 February 2002
- Vol. 39 (1) , 47-53
[Performance evaluation of dual-head coincidence gamma camera for positron imaging].
We assessed the performance evaluation of a dual-head coincidence gamma camera (Millennium VG, General Electric, Milwaukee, USA) as a positron emission tomography (PET) scanner based on the measurement indicator for performance evaluation of PET device. The axial spatial resolution was 4.98 mm FWHM at the center of the field of view. The true high count-rate characteristic curve was relatively straight within the range 0-0.2 microCi/ml. The relative recovery coefficient was 0.1 with a diameter of 10 mm and 0.39 with a diameter of 20 mm. In this study, we had to make a some change in the protocols described in the measurement indicator for performance evaluation of PET devices.
- 1 February 2002
- Vol. 39 (1) , 47-53
[Performance evaluation of dual-head coincidence gamma camera for positron imaging].
We assessed the performance evaluation of a dual-head coincidence gamma camera (Millennium VG, General Electric, Milwaukee, USA) as a positron emission tomography (PET) scanner based on the measurement indicator for performance evaluation of PET device. The axial spatial resolution was 4.98 mm FWHM at the center of the field of view. The true high count-rate characteristic curve was relatively straight within the range 0-0.2 microCi/ml. The relative recovery coefficient was 0.1 with a diameter of 10 mm and 0.39 with a diameter of 20 mm. In this study, we had to make a some change in the protocols described in the measurement indicator for performance evaluation of PET devices.
- 1 May 1998
- Published by Elsevier in NeuroImage
- Vol. 7 (4) , S72
Shifting Attention to Left or Right Hemi-Visualfield Activates Left Parietal Cortex. : A PET Study
- 1 May 1998
- Published by Elsevier in NeuroImage
- Vol. 7 (4) , S72
Shifting Attention to Left or Right Hemi-Visualfield Activates Left Parietal Cortex. : A PET Study
- 30 June 1996
- Published by Elsevier in NeuroImage
- Vol. 3 (3) , S544
Recall process of 3-dimensional and 2-dimensional objects from long term memory studied with positron emission tomography
- 30 June 1996
- Published by Elsevier in NeuroImage
- Vol. 3 (3) , S544
Recall process of 3-dimensional and 2-dimensional objects from long term memory studied with positron emission tomography